drugset / Trial / NCT02785874

Statin With Palliative Therapy for HCC

NCT02785874

RandomizedParallel-groupSingle-blindTreatment

Summary

Statin is a preventive medicine for hepatitis B and hepatitis C which decreases the risk turning into liver cancer,however, the investigators also discovered that patients taking Statin live longer than patients who didn't take Statin in the incidence of liver cancer death cases.

Timeline

Start
2016-09-01
Primary completion
2016-10-01
Completion
2016-11-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosuvastatin Small molecule 10 mg